Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
41.56%
operating margin TTM
44.49%
revenue TTM
2.10 Billion
revenue per share TTM
49.52$
valuation ratios | |
|---|---|
| pe ratio | 17.60 |
| peg ratio | 1.94 |
| price to book ratio | 3.54 |
| price to sales ratio | 7.16 |
| enterprise value multiple | 14.76 |
| price fair value | 3.54 |
profitability ratios | |
|---|---|
| gross profit margin | 86.14% |
| operating profit margin | 44.49% |
| pretax profit margin | 49.87% |
| net profit margin | 41.56% |
| return on assets | 18.16% |
| return on equity | 20.18% |
| return on capital employed | 21.22% |
liquidity ratios | |
|---|---|
| current ratio | 5.73 |
| quick ratio | 5.41 |
| cash ratio | 2.97 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 161.80 |
| operating cycle | 197.70 |
| days of payables outstanding | 415.59 |
| cash conversion cycle | -217.89 |
| receivables turnover | 10.17 |
| payables turnover | 0.88 |
| inventory turnover | 2.26 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 116.95 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 34.17 |
| cash per share | 62.50 |
| operating cash flow per share | 50.43 |
| free cash flow operating cash flow ratio | 0.68 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 3.10 |
Frequently Asked Questions
When was the last time United Therapeutics Corporation (NASDAQ:UTHR) reported earnings?
United Therapeutics Corporation (UTHR) published its most recent earnings results on 05-08-2026.
What is United Therapeutics Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. United Therapeutics Corporation (NASDAQ:UTHR)'s trailing twelve months ROE is 20.18%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. United Therapeutics Corporation (UTHR) currently has a ROA of 18.16%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did UTHR's net profit margin stand at?
UTHR reported a profit margin of 41.56% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is UTHR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.73 in the most recent quarter. The quick ratio stood at 5.41, with a Debt/Eq ratio of 0.00.